Robert A. Sweet

15.2k total citations · 1 hit paper
246 papers, 9.8k citations indexed

About

Robert A. Sweet is a scholar working on Psychiatry and Mental health, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert A. Sweet has authored 246 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Psychiatry and Mental health, 82 papers in Physiology and 66 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert A. Sweet's work include Alzheimer's disease research and treatments (75 papers), Schizophrenia research and treatment (63 papers) and Dementia and Cognitive Impairment Research (63 papers). Robert A. Sweet is often cited by papers focused on Alzheimer's disease research and treatments (75 papers), Schizophrenia research and treatment (63 papers) and Dementia and Cognitive Impairment Research (63 papers). Robert A. Sweet collaborates with scholars based in United States, Canada and Denmark. Robert A. Sweet's co-authors include David A. Lewis, Oscar L. López, Steven T. DeKosky, Benoit H. Mulsant, James T. Becker, Bruce G. Pollock, William E. Klunk, Allan R. Sampson, Daniel C. Javitt and George S. Zubenko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Robert A. Sweet

242 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities

2022 116 citations Robert A. Sweet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Sweet United States	58	4.2k	2.7k	2.0k	1.9k	1.9k	246	9.8k
William G. Honer Canada	59	5.1k 1.2×	2.6k 1.0×	2.7k 1.4×	3.1k 1.6×	2.4k 1.3×	406	14.0k
Orestes Vicente Forlenza Brazil	53	3.7k 0.9×	2.9k 1.1×	1.7k 0.9×	1.1k 0.6×	1.2k 0.6×	288	9.3k
Christopher H. van Dyck United States	49	3.6k 0.9×	5.3k 2.0×	2.6k 1.3×	2.9k 1.5×	2.0k 1.1×	162	13.0k
Wagner F. Gattaz Brazil	64	6.1k 1.4×	2.7k 1.0×	2.5k 1.3×	2.1k 1.1×	2.3k 1.2×	387	14.5k
Melvin G. McInnis United States	55	3.7k 0.9×	1.8k 0.7×	3.0k 1.5×	1.3k 0.7×	2.2k 1.2×	302	11.5k
Breno S. Diniz Brazil	52	3.1k 0.8×	2.8k 1.1×	1.5k 0.8×	933 0.5×	1.2k 0.6×	172	8.8k
Sandro Sorbi Italy	57	3.1k 0.7×	4.6k 1.7×	3.1k 1.5×	1.5k 0.8×	1.8k 0.9×	379	13.0k
Robert M. Cohen United States	52	2.2k 0.5×	2.3k 0.9×	3.2k 1.6×	2.1k 1.1×	2.0k 1.1×	212	12.4k
Kathleen A. Welsh‐Bohmer United States	61	5.8k 1.4×	5.0k 1.9×	2.3k 1.2×	764 0.4×	2.5k 1.3×	233	14.7k
Jarmo Hietala Finland	55	2.8k 0.7×	1.3k 0.5×	1.8k 0.9×	4.4k 2.3×	2.6k 1.4×	239	10.1k

Countries citing papers authored by Robert A. Sweet

Since Specialization

Citations

This map shows the geographic impact of Robert A. Sweet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Sweet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Sweet more than expected).

Fields of papers citing papers by Robert A. Sweet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Sweet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Sweet. The network helps show where Robert A. Sweet may publish in the future.

Co-authorship network of co-authors of Robert A. Sweet

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Sweet. A scholar is included among the top collaborators of Robert A. Sweet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Sweet. Robert A. Sweet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Chen, et al.. (2025). Exploring Potential Medications for Alzheimer’s Disease with Psychosis by Integrating Drug Target Information into Deep Learning Models: A Data-Driven Approach. International Journal of Molecular Sciences. 26(4). 1617–1617. 1 indexed citations

Parnell, Euan, et al.. (2025). Oligodendrocyte myelin glycoprotein impairs dendritic arbors via schizophrenia risk gene Trio. Neurobiology of Disease. 211. 106928–106928.

Zeng, Xuemei, Anuradha Sehrawat, William E. Klunk, et al.. (2024). Large‐scale validation of an improved and resource‐saving immunoprecipitation‐mass spectrometry assay for plasma amyloid‐β biomarkers in Alzheimer's disease. Alzheimer s & Dementia. 20(S2). 1 indexed citations

Lyu, Jun, Matthew L. MacDonald, Sara Ruiz, et al.. (2024). Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation. Neurobiology of Disease. 203. 106731–106731. 1 indexed citations

Needham, Patrick G., et al.. (2023). Differential regulation of MAP2 by phosphorylation events in proline‐rich versus C‐terminal domains. The FASEB Journal. 37(10). e23194–e23194. 5 indexed citations

Kofler, Julia, et al.. (2023). Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease. CPT Pharmacometrics & Systems Pharmacology. 12(8). 1119–1131. 4 indexed citations

DeChellis-Marks, Michael R., Yue Wei, Ying Ding, et al.. (2022). Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels. Frontiers in Neurology. 13. 778419–778419. 8 indexed citations

Grubisha, Melanie, Tao Sun, Susan Erickson, et al.. (2021). A Kalirin missense mutation enhances dendritic RhoA signaling and leads to regression of cortical dendritic arbors across development. Proceedings of the National Academy of Sciences. 118(49). 8 indexed citations

Grubisha, Melanie, Zhe Sun, David A. Lewis, et al.. (2021). MAP2 is differentially phosphorylated in schizophrenia, altering its function. Molecular Psychiatry. 26(9). 5371–5388. 25 indexed citations

10.

McKinney, Brandon C., Lin Huang, Ying Ding, David A. Lewis, & Robert A. Sweet. (2017). DNA methylation evidence against the accelerated aging hypothesis of schizophrenia. Schizophrenia. 3(1). 13–13. 32 indexed citations

11.

McKinney, Brandon C., Ying Ding, David A. Lewis, & Robert A. Sweet. (2017). DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia. Translational Psychiatry. 7(2). e1032–e1032. 22 indexed citations

12.

Mi, Zhiping, Eric E. Abrahamson, Kenneth N. Fish, et al.. (2017). Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease. Neurobiology of Aging. 55. 159–166. 26 indexed citations

13.

Wijsman, Ellen M., Nathan Pankratz, Yoonha Choi, et al.. (2011). Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE. PLoS Genetics. 7(2). e1001308–e1001308. 172 indexed citations

14.

Lewis, David A. & Robert A. Sweet. (2009). Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. Journal of Clinical Investigation. 119(4). 706–716. 173 indexed citations

15.

López, Oscar L., James T. Becker, Robert A. Sweet, Francisco Javier Martín‐Sánchez, & Ronald L. Hamilton. (2006). Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology. 67(4). 660–665. 35 indexed citations

16.

Sweet, Robert A., Ronald L. Hamilton, Meryl A. Butters, et al.. (2004). Neuropathologic Correlates of Late-Onset Major Depression. Neuropsychopharmacology. 29(12). 2242–2250. 82 indexed citations

17.

Sweet, Robert A., et al.. (2002). A Few Corrections to Our Article. Archives of Neurology. 59(6). 1042–1042. 11 indexed citations

18.

Carter, Cameron S., Benoit H. Mulsant, Robert A. Sweet, et al.. (1995). Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications.. PubMed. 31(4). 719–25. 16 indexed citations

19.

Fábrega, Horacio, Benoit H. Mulsant, A H Rifai, et al.. (1994). Ethnicity and Psychopathology in an Aging Hospital-Based Population. The Journal of Nervous and Mental Disease. 182(3). 136–144. 34 indexed citations

20.

Sweet, Robert A. & Heinz W. Wahner. (1977). False-positive fluorescence thyroid scan for ectopic thyroid tissue.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(11). 1142–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact